At a glance
- Originator LEK
- Class Analgesics; Beta-Cyclodextrins; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 08 Jul 1998 Discontinued-Preclinical for Pain in Slovenia (Unknown route)
- 17 Jan 1997 Preclinical development for Pain in Slovenia (Unknown route)